See original article here Darren Rowles is CEO and president of Nova Scotia-based biotech firm Sona Nanotech. Having worked with gold nanoparticles for the past 15 years, he explains the role that they currently play in the healthcare industry and their revolutionary potential. Colloidal gold, the suspension of gold nanoparticles in liquid, has been used for…

See original news release here Gold nanorod manufacturer exploring potential of dual revenue streams for diagnostic, life sciences technology May 14, 2018 – Dartmouth, NS – Atlantic Canada Opportunities Agency Helping Atlantic Canadian businesses succeed in technology-driven global markets is key to generating income, spurring growth and strengthening the middle class and those seeking to join…

See original story here The shareholders of Halifax-based Stockport Exploration have approved the company’s merger with Sona Nanotech, completing another step in the merged company’s path to a stock market listing. The companies on Friday released a statement saying the Stockport shareholders voted 99 percent in favour of the merger last Thursday. The meeting was attended by 18…

See original article here Written  by Darren Rowles , CEO of Sona Nanotech Having been a scientist for more than 15 years, I’ve seen my fair share of science-based startups come and go. Those that succeed tend to do so through a combination of good products, good business sense and good fortune. Often a good enough…

See original article written in Spring 2015 edition of LINK magazine High aspect Gold Nanorods are emerging as a very useful material, with promising applications in “in vivo” medical applications such as; diagnostic imaging and hyperthermal cancer treatment. The use of gold nanorod’s in these applications have been hampered by the fact that current synthesis…

2015 © Copyright - Bionova